1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow riferminogene pecaplasmide: new trials by email Literature Review of riferminogene pecaplasmide trials Research Report on riferminogene pecaplasmide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions riferminogene pecaplasmid, Placebo (for riferminogene pecaplasmid) - Peripheral Vascular Diseases | Phase 3 | Completed | Sanofi | 525 | 2007-11-01 | 2016-05-02 |
Chronic Limb-Threatening Ischemia (1) · Peripheral Arterial Disease (1) · Peripheral Vascular Diseases (1)
Sanofi (1)
Argentina (1) · Australia (1) · Austria (1) · Belarus (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · Czechia (1) · Denmark (1) · Estonia (1) · Finland (1) · France (1) · Germany (1) · Greece (1)